Binder profile
ZINC100727895
Virtual-screening candidate from ZINC.
Bound to: PA3551 — bifunctional mannose-1-phosphate guanylyltransferase/mannose-6-phosphate isomerase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100727895- UniProt (similar protein)
Q9X0C3- Tanimoto
- 0.662
- Target protein
- PA3551
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 347.2
- LogP ≤ 5 -2.50
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 196.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2P(=O)(O)O)c(=O)[nH]1Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2P(=O)(O)O)c(=O)[nH]1
InChI=1S/C10H14N5O7P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(23(19,20)21)5(17)3(1-16)22-9/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1InChI=1S/C10H14N5O7P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(23(19,20)21)5(17)3(1-16)22-9/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1
GWIWQYBELWODMD-UUOKFMHZSA-NGWIWQYBELWODMD-UUOKFMHZSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- GDD
- Homolog
- Q9X0C3
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100727895 →
- ZINC ZINC20 ZINC100727895 →
- UniProt UniProt Q9X0C3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100727895”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3551.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).